 |
|||
|
Orphan disease drugs
Development, Manufacturing, Marketing & Sales of pharmaceuticals for rare and severe diseases in haematology, oncology. and neurology. Sales over 20M€ Sold to EUSA Pharma in 2007 (110M€). |
News :
OPi or how to build a... OPi or how to build a biopharma company in less than 10 years (article issued in Private Equity...
Read more  PDF File
EUSA Pharma Acquires OPi Success stories : EUSA Pharma Inc. acquires d’OPi
> See the press release |
||